loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 22511 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ESOMEPRAZOLE MAGNESIUM; NAPROXEN (2)

filter

01 HORIZON (2)

filter

01 TABLET, DELAYED RELEASE;ORAL (2)

filter

01 EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET, DELAYED RELEAS...
EQ 20MG BASE;375MG **F...
VIMOVO
USA
22511
2010-04-30
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, DELAYED RELEAS...
EQ 20MG BASE;500MG **F...
VIMOVO
USA
22511
2010-04-30
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22511

Looking for CTD TGA MCC DOSSIER APPLICATION 22511 2

19

Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 22511 and regulatory information .

proudly manufactured in the

approval since 2010-04-30

Horizon Therapeutics's VIMOVO TABLET, DELAYED RELEASE;ORAL, medication with EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ESOMEPRAZOLE MAGNESIUM; NAPROXEN.

18

Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 22511 and regulatory information .

proudly manufactured in the

approval since 2010-04-30

Horizon Therapeutics's VIMOVO TABLET, DELAYED RELEASE;ORAL, medication with EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ESOMEPRAZOLE MAGNESIUM; NAPROXEN.

Post Enquiry
POST ENQUIRY